Back to all news
NTU Singapore to Launch Master's in AI in Medicine for Clinicians and Technologists
Tags:Academic
NTU Singapore will launch a new MSc in Artificial Intelligence in Medicine to train clinicians and technologists in clinical AI applications from 2026.
Key Details
- 1NTU is introducing four new Master's programmes in 2026, including one specifically in Artificial Intelligence in Medicine (AIMed).
- 2AIMed will combine clinical practice with technical AI skills, targeting both healthcare professionals and technologists.
- 3It is the first postgraduate programme in Singapore focused on practical and ethical AI integration in healthcare.
- 4The AIMed programme can be completed in up to three years with flexible study pathways.
- 5Graduates will be prepared for new roles such as Clinical AI Specialist, Healthcare Data Scientist, and Chief Medical Information Officer.
Why It Matters
Specialised training in AI for clinicians and technologists is critical for responsible integration of AI in healthcare, particularly in imaging, diagnostics, and data science. This programme represents a significant step towards developing a workforce equipped for the future of AI-driven medicine in the Asia-Pacific region.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.